Subsequent abdominal CT demonstrated slightly larger area of pancreatic necrosis and cyst, but with diffuse gas throught the collection.
Past Medical History: Diabetes, non-insulin dependent Hypertension Lumbar disk bulge (L4) Gallstone pancreatitis as above  Social History: Married, non-drinker   Physical Exam: PE:  98.9  81  101/58  22  95%/2L Gen: NAD, MMdry, (-)jaundice Pul: CTAB Cor: RRR Abd: soft/ND(+)periumbilical tenderness (-)tympani (-)guarding Ext: warm, well perfused  Pertinent Results: [**2165-10-11**] 03:00AM BLOOD WBC-12.3* RBC-3.73* Hgb-12.0* Hct-33.0* MCV-89 MCH-32.2* MCHC-36.3* RDW-15.5 Plt Ct-451*# [**2165-10-12**] 04:19AM BLOOD WBC-28.7*# RBC-3.58* Hgb-11.1* Hct-33.5* MCV-94 MCH-31.0 MCHC-33.1 RDW-15.7* Plt Ct-773* [**2165-10-13**] 07:12PM BLOOD WBC-18.8* RBC-3.08* Hgb-9.6* Hct-27.8* MCV-90 MCH-31.2 MCHC-34.6 RDW-16.3* Plt Ct-428 [**2165-10-18**] 02:30AM BLOOD WBC-8.9 RBC-3.20* Hgb-9.9* Hct-29.3* MCV-92 MCH-30.9 MCHC-33.8 RDW-17.1* Plt Ct-236 [**2165-10-11**] 10:53AM BLOOD Glucose-268* UreaN-12 Creat-0.7 Na-129* K-3.8 Cl-95* HCO3-24 AnGap-14 [**2165-10-14**] 08:51AM BLOOD Glucose-96 UreaN-16 Creat-0.8 Na-128* K-3.8 Cl-98 HCO3-26 AnGap-8 [**2165-10-18**] 02:30AM BLOOD Glucose-139* UreaN-18 Creat-0.7 Na-138 K-4.7 Cl-102 HCO3-31 AnGap-10 [**2165-10-11**] 03:00AM BLOOD ALT-13 AST-15 AlkPhos-83 Amylase-43 TotBili-0.7 [**2165-10-13**] 02:54AM BLOOD ALT-152* AST-286* AlkPhos-63 Amylase-16 TotBili-0.5 [**2165-10-16**] 02:05AM BLOOD ALT-55* AST-45* AlkPhos-89 Amylase-18 TotBili-1.3 [**2165-10-11**] 03:00AM BLOOD Lipase-23 [**2165-10-16**] 02:05AM BLOOD Lipase-14 .
CHEST (PORTABLE AP)  [**2165-10-13**] 12:07 PM [**Hospital 93**] MEDICAL CONDITION: 57 year old man with necrotizing pancreatitis, now septic, recieving massive fluid resuscitation INDICATION: Sepsis.
A single AP view of the chest is obtained semi-upright at 1215 hours and compared with the prior radiograph performed [**2165-10-12**].
[**Hospital1 18**] ECHOCARDIOGRAPHY REPORT  [**Known lastname **], [**Known firstname **]       [**Hospital1 18**] [**Numeric Identifier 74828**]Portable TTE (Complete) Done [**2165-10-15**] at 11:55:01 AM      FINAL Findings Intravenous administration of echo contrast was used due to poor native endocardial border definition.
GENERAL COMMENTS: Suboptimal image quality - poor echo windows.
Overall left ventricular systolic function is normal (LVEF>55%).
The left ventricular inflow pattern suggests impaired relaxation.
CT ABDOMEN W/O CONTRAST  [**2165-10-22**] 1:09 PM IMPRESSION: 1.
CT ABDOMEN W/O CONTRAST  [**2165-11-12**] 11:35 AM IMPRESSION: 1.
Limited study due to lack of intravenous contrast [**Doctor Last Name 360**].
CT HEAD W/O CONTRAST  [**2165-11-16**] 1:16 PM IMPRESSION: 1.
This is the site that on the CT abdomen and pelvis on [**2165-11-12**] had extraluminal oral contrast that was not reported.
[**2165-11-26**] STOOL CLOSTRIDIUM DIFFICILE TOXIN ASSAY-FINAL INPATIENT [**2165-11-24**] STOOL CLOSTRIDIUM DIFFICILE TOXIN ASSAY-FINAL INPATIENT [**2165-11-23**] STOOL CLOSTRIDIUM DIFFICILE TOXIN ASSAY-FINAL INPATIENT [**2165-11-18**] CATHETER TIP-IV WOUND CULTURE-FINAL INPATIENT [**2165-11-18**] SWAB R/O VANCOMYCIN RESISTANT ENTEROCOCCUS-FINAL INPATIENT [**2165-11-18**] MRSA SCREEN MRSA SCREEN-FINAL INPATIENT [**2165-11-18**] MRSA SCREEN MRSA SCREEN-FINAL INPATIENT [**2165-11-12**] URINE URINE CULTURE-FINAL INPATIENT [**2165-11-12**] ABSCESS GRAM STAIN-FINAL; WOUND CULTURE-FINAL {PSEUDOMONAS AERUGINOSA, LACTOBACILLUS SPECIES}; ANAEROBIC CULTURE-FINAL; FUNGAL CULTURE-FINAL INPATIENT [**2165-11-11**] URINE URINE CULTURE-FINAL INPATIENT [**2165-11-4**] SWAB NOT PROCESSED   INPATIENT [**2165-11-4**] SWAB GRAM STAIN-FINAL; WOUND CULTURE-FINAL {PSEUDOMONAS AERUGINOSA}; ANAEROBIC CULTURE-FINAL; FUNGAL CULTURE-FINAL INPATIENT [**2165-11-4**] MRSA SCREEN MRSA SCREEN-FINAL INPATIENT [**2165-11-4**] SWAB R/O VANCOMYCIN RESISTANT ENTEROCOCCUS-FINAL INPATIENT [**2165-11-4**] MRSA SCREEN MRSA SCREEN-FINAL INPATIENT [**2165-11-3**] STOOL CLOSTRIDIUM DIFFICILE TOXIN ASSAY-FINAL INPATIENT [**2165-10-30**] STOOL CLOSTRIDIUM DIFFICILE TOXIN ASSAY-FINAL INPATIENT [**2165-10-28**] STOOL CLOSTRIDIUM DIFFICILE TOXIN ASSAY-FINAL INPATIENT [**2165-10-28**] SWAB R/O VANCOMYCIN RESISTANT ENTEROCOCCUS-FINAL INPATIENT [**2165-10-28**] MRSA SCREEN MRSA SCREEN-FINAL INPATIENT [**2165-10-28**] MRSA SCREEN MRSA SCREEN-FINAL INPATIENT [**2165-10-26**] SWAB GRAM STAIN-FINAL; WOUND CULTURE-FINAL {PROBABLE ENTEROCOCCUS, LACTOBACILLUS SPECIES, GRAM NEGATIVE ROD(S), STAPHYLOCOCCUS, COAGULASE NEGATIVE}; ANAEROBIC CULTURE-FINAL INPATIENT [**2165-10-22**] STOOL CLOSTRIDIUM DIFFICILE TOXIN ASSAY-FINAL INPATIENT [**2165-10-21**] PERITONEAL FLUID GRAM STAIN-FINAL; FLUID CULTURE-FINAL {KLEBSIELLA PNEUMONIAE, VIRIDANS STREPTOCOCCI, STAPHYLOCOCCUS, COAGULASE NEGATIVE}; ANAEROBIC CULTURE-FINAL INPATIENT [**2165-10-21**] BLOOD CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL INPATIENT [**2165-10-21**] URINE URINE CULTURE-FINAL {GRAM POSITIVE COCCUS(COCCI)} INPATIENT [**2165-10-21**] SPUTUM GRAM STAIN-FINAL; RESPIRATORY CULTURE-FINAL INPATIENT [**2165-10-21**] CATHETER TIP-IV WOUND CULTURE-FINAL INPATIENT [**2165-10-21**] MRSA SCREEN MRSA SCREEN-FINAL INPATIENT [**2165-10-21**] SWAB R/O VANCOMYCIN RESISTANT ENTEROCOCCUS-FINAL INPATIENT [**2165-10-21**] MRSA SCREEN MRSA SCREEN-FINAL INPATIENT [**2165-10-14**] MRSA SCREEN MRSA SCREEN-FINAL INPATIENT [**2165-10-14**] SWAB R/O VANCOMYCIN RESISTANT ENTEROCOCCUS-FINAL INPATIENT [**2165-10-14**] MRSA SCREEN MRSA SCREEN-FINAL INPATIENT [**2165-10-12**] BLOOD CULTURE AEROBIC BOTTLE-FINAL; ANAEROBIC BOTTLE-FINAL INPATIENT [**2165-10-11**] SWAB GRAM STAIN-FINAL; WOUND CULTURE-FINAL {KLEBSIELLA PNEUMONIAE, VIRIDANS STREPTOCOCCI}; ANAEROBIC CULTURE-FINAL; FUNGAL CULTURE-FINAL .
He went to the OR for pancreatic necrosectomy on [**10-11**] (1 liter of purulent fluid), cholecystostomy tube, g tube, j tube, [**Doctor Last Name 406**] X 4 (#1-gallbladder area, #2-pancreatic head, #3-body, #4-tail)  He remained intubated in the ICU with drains in place  Significant Events: -[**10-11**], underwent debridement of his pancreas with 1.5L of pus drained -[**10-14**] his wound culture started growing pan-sensitive Klebsiella and Viridans strep.
-[**10-23**] Washout: peritoneal fluid grew Klebsiella, Viridans strep and rare coagulase negative staph.
-[**10-28**] Ex lap, washout and debridement; wound grew enterococcus(mod), lactobacillus(mod), gram negative rods(sparse) and coag negative staph(sparse).
-[**11-4**] abd swab: Pseudomonas (S to ceftaz) -[**11-12**] CT showed a gastic fistula, and decreased pancreatic fluid collection -[**11-16**] Head CT WNL.
Culture: [**10-11**] pancreatic abscess: Klebsiella (pan S), S. viridans [**10-21**] peritoneal fluid: Klebsiella (pan S) [**10-21**] blood: neg [**10-26**] abd swab: prob Enterococcus, Lactobacillus, GNRs sparse growth, coag neg Staph [**11-3**] C. diff: neg [**11-4**] abd swab: Pseudomonas (S to ceftaz) [**11-12**] ucx: neg [**11-12**] wound cx: Pseudomonas (S to ceftaz), Lactobacillus [**11-18**] MRSA & VRE screen: neg [**11-18**] cath tip: neg [**11-23**] C.diff: neg [**11-24**] C.diff: neg  ID was following along.
Prior ABX: Flagyl [**Date range (1) 74831**] Meropenem [**10-11**]- Vanco([**Date range (1) 74832**], [**Date range (1) 74833**] Gentamicin([**11-6**]- ABX: CeftazIDIME 2 gm IV Q8H ([**11-7**]-) Colistin 120 mg IV Q12H ([**11-7**]-) Fluconazole 400 mg IV Q24H ([**Date range (1) 74834**]) Vancomycin 1000 mg IV Q 12H ([**Date range (1) 74833**]) MICRO: 10/5 BLOOD No growth [**10-11**] SWAB: KLEBSIELLA PNEUMONIAE Pan sensitive [**10-21**] BLOOD No growth [**10-23**] Peritoneal Fluid: :KLEBSIELLA PNEUMONIAE-Pan sensitive.
[**11-4**] SWAB: PSEUDOMONAS AERUGINOSA Resistant to all but Ceftaz, colistin sensi pend C.Diff toxin negative [**10-22**], [**10-28**], [**10-30**], 10/28 [**11-10**]: Renal function slightly worse today cont cef/colisitin day [**3-11**] Sensi return Intermediate to amikacin await sensi to colistin [**11-11**]: Creat up to 1.7 (baseline 0.6).
CT showed oral contrast extravasating into pancreatic area, concerning for enteric fistula.
Creatinine stable and expect tubules to heal over time.
[**11-14**]: Creatinine=2.3 (plateaued), supportive ATN care and renally-dosing meds [**11-15**]: Cr plateaued and UOP excellent, tubules expected to heal over 10-14 days.
He had a +grape juice test at the bedside, with extravasation of juice.
He improved gradually, and was able to maintain his blood pressure with transfers and sitting.
Docusate Sodium 50 mg/5 mL Liquid [**Month/Year (2) **]: Two (2)  PO BID (2 times a day).
Followup Instructions: Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 2832**], MD Phone:[**Telephone/Fax (1) 2833**] Date/Time:[**2165-12-27**] 9:00 Provider: [**Name Initial (NameIs) **] SUITE GI ROOMS Date/Time:[**2166-1-14**] 4:00 Provider: [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1982**], MD Phone:[**Telephone/Fax (1) 1983**] Date/Time:[**2166-1-14**] 4:00 Please follow-up with [**Hospital **] [**Hospital 982**] Clinic.
